Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer.
Petrioli R, Marrelli D, Roviello F, D'Ignazio A, Torre P, Chirra M, Savelli V, Ambrosio MR, Francini G, Calomino N, Farsi M, Vernillo R, Francini E. Petrioli R, et al. Among authors: ambrosio mr. Surg Oncol. 2020 Mar;32:2-7. doi: 10.1016/j.suronc.2019.10.002. Epub 2019 Oct 2. Surg Oncol. 2020. PMID: 31670056
Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis.
Molinari C, Tedaldi G, Rebuzzi F, Morgagni P, Capelli L, Ravaioli S, Tumedei MM, Scarpi E, Tomezzoli A, Bernasconi R, Ambrosio MR, D'Ignazio A, Solaini L, Limarzi F, Ercolani G, Martinelli G, Ulivi P, Saragoni L. Molinari C, et al. Among authors: ambrosio mr. Gastric Cancer. 2021 Mar;24(2):392-401. doi: 10.1007/s10120-020-01135-8. Epub 2020 Nov 6. Gastric Cancer. 2021. PMID: 33156452
Validating a nodal regression system for gastric cancer: An ancillary cohort study of the GASTRODOC trial.
Saragoni L, Solaini L, Marrelli D, Ambrosio MR, Bencivenga M, Tomezzoli A, Milandri C, Terrinazzi V, Baiocchi GL, Baronchelli C, Foca F, Ercolani G, Morgagni P. Saragoni L, et al. Among authors: ambrosio mr. Int J Surg. 2021 Oct;94:106112. doi: 10.1016/j.ijsu.2021.106112. Epub 2021 Sep 15. Int J Surg. 2021. PMID: 34536601 Free article. Clinical Trial.
The Percentage of Signet Ring Cells Is Inversely Related to Aggressive Behavior and Poor Prognosis in Mixed-Type Gastric Cancer.
Marano L, Ambrosio MR, Resca L, Carbone L, Carpineto Samorani O, Petrioli R, Savelli V, Costantini M, Malaspina L, Polom K, Biviano I, Marrelli D, Roviello F. Marano L, et al. Among authors: ambrosio mr. Front Oncol. 2022 May 26;12:897218. doi: 10.3389/fonc.2022.897218. eCollection 2022. Front Oncol. 2022. PMID: 35719955 Free PMC article.
Peripancreatic paraganglioma: Lesson from a round table.
Petrelli F, Fratini G, Sbrozzi-Vanni A, Giusti A, Manta R, Vignali C, Nesi G, Amorosi A, Cavazzana A, Arganini M, Ambrosio MR. Petrelli F, et al. Among authors: ambrosio mr. World J Gastroenterol. 2022 Jun 7;28(21):2396-2402. doi: 10.3748/wjg.v28.i21.2396. World J Gastroenterol. 2022. PMID: 35800185 Free PMC article.
Immunohistochemical Markers of the Epithelial-to-Mesenchymal Transition (EMT) Are Related to Extensive Lymph Nodal Spread, Peritoneal Dissemination, and Poor Prognosis in the Microsatellite-Stable Diffuse Histotype of Gastric Cancer.
Marrelli D, Marano L, Ambrosio MR, Carbone L, Spagnoli L, Petrioli R, Ongaro A, Piccioni S, Fusario D, Roviello F. Marrelli D, et al. Among authors: ambrosio mr. Cancers (Basel). 2022 Dec 7;14(24):6023. doi: 10.3390/cancers14246023. Cancers (Basel). 2022. PMID: 36551509 Free PMC article.
256 results